Reaction
Daydreaming reporting signals
As of the last recalculation, Daydreaming appears in 1,526 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is RIVASTIGMINE (PRR 16.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rivastigmine | 23 | 16.9 | 16.9 |
| Sotalol Hydrochloride | 15 | 12.4 | 12.4 |
| Felodipine Extended-Release Tablets | 10 | 12.0 | 12.1 |
| Felodipine | 10 | 12.0 | 12.1 |
| Rotigotine | 12 | 11.4 | 11.4 |
| Oxcarbazepine | 25 | 10.6 | 10.7 |
| Atomoxetine Hydrochloride | 17 | 9.8 | 9.8 |
| Selinexor | 6 | 9.5 | 9.5 |
| Insulin Glulisine | 7 | 9.4 | 9.4 |
| Zonisamide | 10 | 9.3 | 9.3 |
| Abemaciclib | 12 | 8.2 | 8.3 |
| Brivaracetam | 5 | 7.6 | 7.6 |
| Voclosporin | 4 | 6.3 | 6.3 |
| Lisdexamfetamine Dimesylate | 15 | 6.3 | 6.3 |
| Bosutinib | 4 | 6.1 | 6.1 |
| Varenicline Tartrate | 34 | 5.9 | 5.9 |
| Methylphenidate | 12 | 5.7 | 5.7 |
| Lurasidone Hydrochloride | 8 | 5.2 | 5.2 |
| Ethyl Alcohol | 10 | 5.0 | 5.0 |
| Cenobamate | 3 | 4.9 | 4.9 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 3 | 4.8 | 4.8 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 4.4 | 4.4 |
| Suvorexant | 4 | 4.2 | 4.2 |
| Brexpiprazole | 5 | 4.1 | 4.1 |
| Cannabidiol | 7 | 4.1 | 4.1 |
| Pimavanserin Tartrate | 15 | 3.7 | 3.7 |
| Relugolix | 4 | 2.3 | 2.3 |